The Office of Management and Budget clarified President Trump’s new “one in, two out” regulations order, narrowing its scope to significant regulations with an economic impact of over $100 million per year — and said the release of new guidance documents would be considered on a case-by-case basis.

Regulatory actions required by law may also proceed — such as provisions in the 21st Century Cures Act requiring the FDA and HHS to publish guidance and issue rules — without identifying cuts, if agencies are facing a legal deadline.

Agencies should also “confirm that they will continue to achieve their regulatory objectives,” when identifying the two regulations to be cut for each new one proposed, the White House said. — Jeff Kinney